Quantification of hyperreflexia in amyotrophic lateral sclerosis (ALS) by the soleus stretch reflex

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

Volumn 4, Issue 2, 2003, Pages 106-111

  Christensen, Peter Brøgger ^a   Nielsen, Jørgen F ^a   Sinkjær, Thomas ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

Author keywords

Amyotrophic lateral sclerosis; Clinical sore; Soleus stretch reflex; Stiffness; Upper motor neuron

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANKLE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ELECTROMYOGRAM; FEMALE; HUMAN; HYPERREFLEXIA; LATENT PERIOD; MALE; MOTONEURON; MUSCLE CONTRACTION; MYOTATIC REFLEX; NERVE STIMULATION; PATIENT MONITORING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SENSITIVITY ANALYSIS; SOLEUS MUSCLE; TIBIAL NERVE;

EID: 0038446764     PISSN: 14660822     EISSN: None     Source Type: Journal    
DOI: 10.1080/14660820310012754     Document Type: Article

References (28)

1. Shaw PJ, Ince PG. Glutamate, excitotoxicity and amyotrophic lateral sclerosis. J Neurol 1997; 244 (suppl 2): 3-14.
2. Rothstein JD. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. Adv Neurol 1995; 68: 7-20.
3. Kamper DG, Rymer WZ. Quantitative features of the stretch response of extrinsic finger muscles in hemiparetic stroke. Muscle Nerve 2000; 23: 954-961.
4. Ada L, Vattanasilp W, O'Dwyer NJ, Crosbie J. Does spasticity contribute to walking dysfunction after stroke? J Neurol Neurosurg Psychiatry 1998; 64: 628-635.
5. Sinkjaer T, Magnussen I. Passive, intrinsic and reflex-mediated stiffness in the ankle extensors of hemiparetic patients. Brain 1994; 117: 355-363.
6. Nielsen JF, Anderson JB, Sinkjaer T. Baclofen increases the soleus stretch reflex threshold in the early swing phase during walking in spastic multiple sclerosis patients. Mult Scler 2000; 6: 105-14.
7. Nielsen JF, Sinkjaer T. Peripheral and central effect of baclofen on ankle joint stiffness in multiple sclerosis. Muscle Nerve 2000; 23: 98-105.
8. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994; 124 (suppl): 96-107.
9. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group. Arch Neurol 1996; 53: 141-147.
10. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964; 192: 540-542.
11. Sinkjaer T, Toft E, Andreassen S, Hornemann BC. Muscle stiffness in human ankle dorsiflexors: intrinsic and reflex components. J Neurophysiol 1988; 60: 1110-1121.
12. Sinkjaer T, Toft E, Larsen K, Andreassen S, Hansen HJ. Non-reflex and reflex mediated ankle joint stiffness in multiple sclerosis patients with spasticity. Muscle Nerve 1993; 16: 69-76.
13. Andres PL, Hedlund W, Finison L et al. Quantitative motor assessment in amyotrophic lateral sclerosis. Neurology 1986; 36:937-941.
14. Kelly JJ, Thibodeau L, Andres PL, Finison LJ. Use of electrophysiologic tests to measure disease progression in ALS therapeutic trials. Muscle Nerve 1990; 13: 471-479.
15. Bromberg MB, Forshew DA, Nau KL et al. Motor unit number estimation, isometric strength, and electromyographic measures in amyotrophic lateral sclerosis. Muscle Nerve 1993; 16: 1213-1219.
16. Armon C, Brandstater ME. Motor unit number estimate-based rates of progression of ALS predict patient survival. Muscle Nerve 1999; 22: 1571-1575.
17. De Carvalho M, Swash M. Nerve conduction studies in amyotrophic lateral sclerosis. Muscle Nerve 2000; 23: 344-352.
18. Eisen A, Shytbel W, Murphy K, Hoirch M. Cortical magnetic stimulation in amyotrophic lateral sclerosis. Muscle Nerve 1990; 13: 146-151.
19. Pouget J, Trefouret S, Attarian S. Transcortical magnetic stimulation. In: Brown RH, Meininger V, Swash M, Editors, Amyotrophic lateral sclerosis, Martin Dunitz, UK 2000, pp 179-185.
20. Pohl C, Block W, Karitzky J et al. Proton magnetic resonance spectroscopy of motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch Neurol 2001; 51: 729-735.
21. Pohl C, Block W, Traber F et al. Proton magnetic resonance spectroscopy and transcranial magnetic stimulation for the detection of upper motor neuron degeneration in ALS patients. J Neurol Sci 2001; 190(1-2): 21-27.
22. Rosler KM, Truffert A, Hess CW, Magistris MR. Quantification of upper motor neuron loss in amyotrophic lateral sclerosis. Clin Neurophysiol 2000; 111: 2208-2218.
23. Ellis CM, Simmons A, Jones DK, Bland et al. Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology 1999; 53: 1051-1058.
24. Nielsen JF, Sinkjaer T. A comparison of clinical and laboratory measures of spasticity. Mult Scler 1996; 1: 296-301.
25. Sinkjaer T, Andersen JB, Nielsen JF. Impaired stretch reflex and joint torque modulation during spastic gait in multiple sclerosis patients. J Neurol 1996; 243: 566-574.
26. Nielsen JF, Andersen JB, Barbeau. H, Sinkjaer T. Input-output properties of the soleus stretch reflex in spastic stroke patients and healthy subjects during walking. NeuroRehabilitation 1998; 10: 151-166.
27. Andres PL, Skerry LM, Thornell B et al. A comparison of three measures of disease progression in ALS. J Neurol Sci 1996; 139 (suppl): 64-70.
28. Hourseham E, Swash M. Diagnostic delay in amyotrophic lateral sclerosis: what scope for improvement? J Neurol Sci 2000; 180: 76-81.